Chu Victor C, McElroy Lisa J, Chu Vicky, Bauman Beverley E, Whittaker Gary R
Dept. of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
J Virol. 2006 Apr;80(7):3180-8. doi: 10.1128/JVI.80.7.3180-3188.2006.
Coronaviruses are the causative agents of respiratory disease in humans and animals, including severe acute respiratory syndrome. Fusion of coronaviruses is generally thought to occur at neutral pH, although there is also evidence for a role of acidic endosomes during entry of a variety of coronaviruses. Therefore, the molecular basis of coronavirus fusion during entry into host cells remains incompletely defined. Here, we examined coronavirus-cell fusion and entry employing the avian coronavirus infectious bronchitis virus (IBV). Virus entry into cells was inhibited by acidotropic bases and by other inhibitors of pH-dependent endocytosis. We carried out fluorescence-dequenching fusion assays of R18-labeled virions and show that for IBV, coronavirus-cell fusion occurs in a low-pH-dependent manner, with a half-maximal rate of fusion occurring at pH 5.5. Fusion was reduced, but still occurred, at lower temperatures (20 degrees C). We observed no effect of inhibitors of endosomal proteases on the fusion event. These data are the first direct measure of virus-cell fusion for any coronavirus and demonstrate that the coronavirus IBV employs a direct, low-pH-dependent virus-cell fusion activation reaction. We further show that IBV was not inactivated, and fusion was unaffected, by prior exposure to pH 5.0 buffer. Virions also showed evidence of reversible conformational changes in their surface proteins, indicating that aspects of the fusion reaction may be reversible in nature.
冠状病毒是人类和动物呼吸道疾病的病原体,包括严重急性呼吸综合征。冠状病毒的融合通常被认为发生在中性pH值条件下,尽管也有证据表明酸性内体在多种冠状病毒进入过程中发挥作用。因此,冠状病毒进入宿主细胞过程中融合的分子基础仍未完全明确。在此,我们利用禽冠状病毒传染性支气管炎病毒(IBV)研究了冠状病毒与细胞的融合及进入过程。病毒进入细胞受到亲酸性碱和其他pH依赖性内吞作用抑制剂的抑制。我们对R18标记的病毒粒子进行了荧光猝灭融合试验,结果表明,对于IBV,冠状病毒与细胞的融合以低pH依赖性方式发生,融合半最大速率出现在pH 5.5时。在较低温度(20摄氏度)下,融合减少但仍会发生。我们观察到内体蛋白酶抑制剂对融合事件没有影响。这些数据是对任何冠状病毒病毒与细胞融合的首次直接测量,表明冠状病毒IBV采用直接的、低pH依赖性的病毒与细胞融合激活反应。我们进一步表明,预先暴露于pH 5.0缓冲液不会使IBV失活,且融合不受影响。病毒粒子表面蛋白也显示出可逆构象变化的证据,表明融合反应的某些方面在本质上可能是可逆的。